A Literature Review of the Cardiovascular Risk-assessment Tools: Applicability Among Asian Population

Overview

Journal Heart Asia

Date 2016 Jun 22

PMID 27325935

Citations 12

Authors

Siow Yen Liau

M I Mohamed Izham

M A Hassali

A A Shafie

Affiliations

Soon will be listed here.

Abstract

Background: Cardiovascular diseases, the main causes of hospitalisations and death globally, have put an enormous economic burden on the healthcare system. Several risk factors are associated with the occurrence of cardiovascular events. At the heart of efficient prevention of cardiovascular disease is the concept of risk assessment. This paper aims to review the available cardiovascular risk-assessment tools and its applicability in predicting cardiovascular risk among Asian populations.

Methods: A systematic search was performed using keywords as MeSH and Boolean terms.

Results: A total of 25 risk-assessment tools were identified. Of these, only two risk-assessment tools (8%) were derived from an Asian population. These risk-assessment tools differ in various ways, including characteristics of the derivation sample, type of study, time frame of follow-up, end points, statistical analysis and risk factors included.

Conclusions: Very few cardiovascular risk-assessment tools were developed in Asian populations. In order to accurately predict the cardiovascular risk of our population, there is a need to develop a risk-assessment tool based on local epidemiological data.

Citing Articles

A Comparison of Statin Treatment Algorithms Based on the ACC/AHA and Philippine Guidelines for Primary Prevention of Dyslipidemia in Statin-Naive Filipino Patients.

Maglinte B, Junia A, Robles J J ASEAN Fed Endocr Soc. 2022; 37(2):34-41.

PMID: 36578900 PMC: 9758551. DOI: 10.15605/jafes.037.02.16.

"Healthy Heart, Healthy You": Ten-Year Cardiovascular Disease (CVD) Risk among Adults in Anekal Taluk Hospital, Bangalore Urban District, Karnataka.

Kannan R, Kiran P, Gnanaselvam N, Mathew K, Johnson J Indian J Community Med. 2022; 47(3):429-432.

PMID: 36438540 PMC: 9693965. DOI: 10.4103/ijcm.ijcm_825_21.

Deep Learning Improves Prediction of Cardiovascular Disease-Related Mortality and Admission in Patients with Hypertension: Analysis of the Korean National Health Information Database.

Lee S, Lee S, Choi H, Lee J, Jeong Y, Kang D J Clin Med. 2022; 11(22).

PMID: 36431154 PMC: 9697313. DOI: 10.3390/jcm11226677.

Cardiovascular risk assessment tools in Asia.

Zhang Y, Miao H, Chia Y, Buranakitjaroen P, Siddique S, Shin J J Clin Hypertens (Greenwich). 2022; 24(4):369-377.

PMID: 34981620 PMC: 8989745. DOI: 10.1111/jch.14336.

Validation of the World Health Organization/ International Society of Hypertension (WHO/ISH) cardiovascular risk predictions in Sri Lankans based on findings from a prospective cohort study.

Thulani U, Mettananda K, Warnakulasuriya D, Peiris T, Kasturiratne K, Ranawaka U PLoS One. 2021; 16(6):e0252267.

PMID: 34097699 PMC: 8183983. DOI: 10.1371/journal.pone.0252267.

References

Volpe M, Erhardt L, Williams B . Managing cardiovascular risk: the need for change. J Hum Hypertens. 2007; 22(2):154-7. DOI: 10.1038/sj.jhh.1002273. View

Kannel W . Clinical misconceptions dispelled by epidemiological research. Circulation. 1995; 92(11):3350-60. DOI: 10.1161/01.cir.92.11.3350. View

Barzi F, Patel A, Gu D, Sritara P, Lam T, Rodgers A . Cardiovascular risk prediction tools for populations in Asia. J Epidemiol Community Health. 2007; 61(2):115-21. PMC: 2465638. DOI: 10.1136/jech.2005.044842. View

DAgostino Sr R, Grundy S, Sullivan L, Wilson P . Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA. 2001; 286(2):180-7. DOI: 10.1001/jama.286.2.180. View

Swan H . The Framingham Offspring Study: a commentary. 1980. J Am Coll Cardiol. 1999; 33(5):1136-40. DOI: 10.1016/s0735-1097(99)00089-3. View

ODonnell C, Elosua R . [Cardiovascular risk factors. Insights from Framingham Heart Study]. Rev Esp Cardiol. 2008; 61(3):299-310. View

Giampaoli S, Palmieri L, Mattiello A, Panico S . Definition of high risk individuals to optimise strategies for primary prevention of cardiovascular diseases. Nutr Metab Cardiovasc Dis. 2005; 15(1):79-85. DOI: 10.1016/j.numecd.2004.12.001. View

DAgostino Sr R, Vasan R, Pencina M, Wolf P, Cobain M, Massaro J . General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008; 117(6):743-53. DOI: 10.1161/CIRCULATIONAHA.107.699579. View

DAlton M, Cameron A, Zimmet P, Shaw J, Jolley D, Dunstan D . Waist circumference, waist-hip ratio and body mass index and their correlation with cardiovascular disease risk factors in Australian adults. J Intern Med. 2003; 254(6):555-63. DOI: 10.1111/j.1365-2796.2003.01229.x. View

10.

Redberg R, Benjamin E, Bittner V, Braun L, Goff Jr D, Havas S . ACCF/AHA 2009 performance measures for primary prevention of cardiovascular disease in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures (Writing Committee to Develop.... J Am Coll Cardiol. 2009; 54(14):1364-405. DOI: 10.1016/j.jacc.2009.08.005. View

11.

Kinosian B, GLICK H, Garland G . Cholesterol and coronary heart disease: predicting risks by levels and ratios. Ann Intern Med. 1994; 121(9):641-7. DOI: 10.7326/0003-4819-121-9-199411010-00002. View

12.

Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, May M, Brindle P . Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study. BMJ. 2007; 335(7611):136. PMC: 1925200. DOI: 10.1136/bmj.39261.471806.55. View

13.

Smith Jr S . Current and future directions of cardiovascular risk prediction. Am J Cardiol. 2006; 97(2A):28A-32A. DOI: 10.1016/j.amjcard.2005.11.013. View

14.

Pastor-Barriuso R, Banegas J, Damian J, Appel L, Guallar E . Systolic blood pressure, diastolic blood pressure, and pulse pressure: an evaluation of their joint effect on mortality. Ann Intern Med. 2003; 139(9):731-9. DOI: 10.7326/0003-4819-139-9-200311040-00007. View

15.

Tonkin A, Lim S, Schirmer H . Cardiovascular risk factors: when should we treat?. Med J Aust. 2003; 178(3):101-2. DOI: 10.5694/j.1326-5377.2003.tb05092.x. View

16.

Chow C, Joshi R, Celermajer D, Patel A, Neal B . Recalibration of a Framingham risk equation for a rural population in India. J Epidemiol Community Health. 2009; 63(5):379-85. DOI: 10.1136/jech.2008.077057. View

17.

Panagiotakos D, Stavrinos V . Methodological issues in cardiovascular epidemiology: the risk of determining absolute risk through statistical models. Vasc Health Risk Manag. 2007; 2(3):309-15. PMC: 1993982. DOI: 10.2147/vhrm.2006.2.3.309. View

18.

Jackson R . Cardiovascular risk prediction: are we there yet?. Heart. 2007; 94(1):1-3. DOI: 10.1136/hrt.2007.138040. View

19.

Suka M, Sugimori H, Yoshida K . Application of the updated Framingham risk score to Japanese men. Hypertens Res. 2002; 24(6):685-9. DOI: 10.1291/hypres.24.685. View

20.

Lloyd-Jones D, Leip E, Larson M, DAgostino R, Beiser A, Wilson P . Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age. Circulation. 2006; 113(6):791-8. DOI: 10.1161/CIRCULATIONAHA.105.548206. View